Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • For authors
    • Instructions for authors
    • Submit a manuscript
    • Author FAQs
    • Open access
    • COVID-19 submission information
  • Alerts
  • Podcasts
  • Subscriptions

Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study

Marloes P. Huitema, Annelies L.M. Bakker, Johannes J. Mager, Benno J.W.M. Rensing, Fokko Smits, Repke J. Snijder, Jan C. Grutters, Marco C. Post
European Respiratory Journal 2019 54: 1900897; DOI: 10.1183/13993003.00897-2019
Marloes P. Huitema
1Dept of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mp.huitema@antoniusziekenhuis.nl
Annelies L.M. Bakker
1Dept of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes J. Mager
2Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benno J.W.M. Rensing
1Dept of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fokko Smits
3Dept of Radiology, St Antonius Hospital, Nieuwegein, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Repke J. Snijder
2Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jan C. Grutters
2Dept of Pulmonology, St Antonius Hospital, Nieuwegein, The Netherlands
4Dept of Pulmonology, University Medical Centre Utrecht, Utrecht, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marco C. Post
1Dept of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Extract

Sarcoidosis is a systemic disease of an unknown aetiology, in which noncaseating granulomas are formed in one or multiple organs, with pulmonary involvement in >90% of the sarcoidosis patients [1]. Pulmonary hypertension (PH), defined as a mean pulmonary artery pressure of ≥25 mmHg by right heart catheterisation (RHC) [2], is a well recognised complication of sarcoidosis, associated with significant increase in mortality [3, 4]. Although the first case of PH in sarcoidosis was described in 1949 [5], the exact prevalence remains unclear.

Abstract

The prevalence of pulmonary hypertension in sarcoidosis seems to differ between ethnicities and was never investigated in a Caucasian cohort. This study shows a prevalence of 3% in a Caucasian cohort, significantly lower compared to other ethnicities. http://bit.ly/2kRMrap

Footnotes

  • Conflict of interest: M.P. Huitema has nothing to disclose.

  • Conflict of interest: A.L.M. Bakker has nothing to disclose.

  • Conflict of interest: J.J. Mager has nothing to disclose.

  • Conflict of interest: B.J.W.M. Rensing has nothing to disclose.

  • Conflict of interest: F. Smits has nothing to disclose.

  • Conflict of interest: R.J. Snijder has nothing to disclose.

  • Conflict of interest: J.C. Grutters has nothing to disclose.

  • Conflict of interest: M.C. Post has nothing to disclose.

  • Support statement: Funding was received from ZonMw (The Netherlands Organisation for Health Research and Development). Funding information for this article has been deposited with the Crossref Funder Registry.

  • Received November 29, 2018.
  • Accepted June 12, 2019.
  • Copyright ©ERS 2019
https://www.ersjournals.com/user-licence
View Full Text

ERS Members

myERS - ERS members : log in with your myERS username and password.

INDIVIDUALS

Log in Login as an individual user.

Forgot your username or password?

LIBRARY USERS

Log in through your institution

If your library has a subscription, you may already be logged in via your IP address. Otherwise you may be able to log in via one of the following routes.
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
If you think you should have access, please contact your librarian or email journals@ersnet.org

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top
View this article with LENS
Vol 54 Issue 4 Table of Contents
European Respiratory Journal: 54 (4)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study
Marloes P. Huitema, Annelies L.M. Bakker, Johannes J. Mager, Benno J.W.M. Rensing, Fokko Smits, Repke J. Snijder, Jan C. Grutters, Marco C. Post
European Respiratory Journal Oct 2019, 54 (4) 1900897; DOI: 10.1183/13993003.00897-2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study
Marloes P. Huitema, Annelies L.M. Bakker, Johannes J. Mager, Benno J.W.M. Rensing, Fokko Smits, Repke J. Snijder, Jan C. Grutters, Marco C. Post
European Respiratory Journal Oct 2019, 54 (4) 1900897; DOI: 10.1183/13993003.00897-2019
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Shareable PDF
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Lower lung function in patients recovering from COVID-19
  • Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis
  • Ethical obligations for supporting healthcare workers during the COVID-19 pandemic
Show more Agora

Research letters

  • Lower lung function in patients recovering from COVID-19
  • Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis
  • Ethical obligations for supporting healthcare workers during the COVID-19 pandemic
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • CME
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Submit a manuscript
  • ERS author centre

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2021 by the European Respiratory Society